TC
TNDM icon

TFS Capital’s Tandem Diabetes Care TNDM Stock Holding History

TFS Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,917
Closed -$106K – 849
2016
Q4 		$106K Buy
+4,917
New +$189K 0.03% 632

Other funds holding TNDM

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TFS Capital's TNDM Position: Q1 2017 in Review

TFS Capital sold out of Tandem Diabetes Care (TNDM) in Q1 2017, closing a stake of 4,917 shares — an estimated $106K sold.

TFS Capital first reported a position in TNDM in Q4 2016 and held it in 1 quarter. The position peaked at $106K in Q4 2016. 80 funds tracked by Wall St. Rank hold TNDM as of Q1 2017.

  • TFS Capital reported no remaining Tandem Diabetes Care position as of Q1 2017 after selling out during the quarter.
  • TFS Capital sold 4,917 Tandem Diabetes Care shares in Q1 2017, an estimated $106K.
  • TFS Capital first reported a position in Tandem Diabetes Care in Q4 2016 and held it in 1 quarter.
  • TFS Capital's Tandem Diabetes Care position peaked at $106K in Q4 2016.
  • 80 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2017.

Based on TFS Capital's 13F filing for Q1 2017, filed 5 May 2017.